78
Clinical Trial
Research archive
Immunology
84
Research Article
THRIVE: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of Veligrotug for Active Thyroid Eye Disease.
86
Research Article
Repurposing leflunomide and hydroxychloroquine to treat Sjögren’s disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial.
86
Clinical Trial
Darvadstrocel in Patients With Crohn’s Disease With Complex Perianal Fistulas: The ADMIRE CD II Phase 3 Randomized Trial.
80
Randomized Controlled Trial
Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study).
80
Meta-Analysis
Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis.
94
Clinical Trial
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.
93
Clinical Trial
Telitacicept for IgA Nephropathy – Interim Analysis of a Phase 3 Trial.
81
Research Article
Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial.
83
Research Article
Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton’s tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled study.
82
Clinical Trial
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.
79
Research Article